With the analysis among 175 patents, we discovered top 50 key players by total patent application. Eli Lilly & Co., Kindred Biosciences, Inc., Cephalon, Inc. are dominant in this area. They take 31.43% of the total patent filing.
Indiana, United States
Patent: 26
California, United States
Patent: 18
Pennsylvania, United States
Patent: 11
California, United States
Patent: 11
Washington, United States
Patent: 9
British Columbia, Canada
Patent: 7
California, United States
Patent: 6
California, United States
Patent: 6
Basel-Stadt, Switzerland
Patent: 5
With the analysis among 25 patents, we discovered top 4 start-ups by total patent application. Biosplice Therapeutics, Inc., Aiviva Biopharma, Inc., Dermavant Sciences GmbH are active in this area.
California, United States
Patent: 11
California, United States
Patent: 6
Basel-Stadt, Switzerland
Patent: 5
California, United States
Patent: 3
With the analysis among related 115 patents applied in the last 5 years. We discover 32 most active companies in this area. The fast-growing Eli Lilly & Co., Kindred Biosciences, Inc., Biosplice Therapeutics, Inc. take 46.96% of patent filing during this period.
Indiana, United States
Patent: 26
California, United States
Patent: 18
California, United States
Patent: 10
Pennsylvania, United States
Patent: 7
California, United States
Patent: 3
Basel-Stadt, Switzerland
Patent: 3
Basel-Stadt, Switzerland
Patent: 3
Washington, United States
Patent: 2
With the analysis among related 115 patents in last 5 years, we discover 23 new entrants. Eli Lilly & Co., Kindred Biosciences, Inc., C&C Research Laboratories are the most active new entrants in this area.
Indiana, United States
Patent: 26
California, United States
Patent: 18
California, United States
Patent: 3
Basel-Stadt, Switzerland
Patent: 3
Zhejiang Sheng, China
Patent: 2
Virginia, United States
Patent: 1
Hordaland, Norway
Patent: 1
With the analysis among 10 patents, we discovered top 1 universities and scientific research institutions by total patent application.
Uttar Pradesh, India
Patent: 1